Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma

Naoko Yamada1, Koji Yamanegi, Hideki Ohyama

  • 1Department of Pathology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan. ynaoko@hyo-med.ac.jp

Insights

Hypoxia reduces NKG2D ligand MICA on osteosarcoma cells, decreasing NK cell attacks. This effect is dependent on hypoxia-inducible factor-1α (HIF-1α) and not nitric oxide production.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Physiology

Background:

  • Tumor cells express NKG2D ligands, recognized by activating receptor NKG2D on NK cells, leading to tumor cell lysis.
  • The interaction between NKG2D and its ligands is crucial for NK cell-mediated anti-tumor immunity.

Purpose of the Study:

  • To investigate the impact of hypoxia on NKG2D ligand expression in human osteosarcoma cells.
  • To elucidate the mechanisms underlying hypoxia's effects on NKG2D ligand expression and NK cell cytotoxicity.

Main Methods:

  • Osteosarcoma cell lines were cultured under hypoxic (1% O2) and normoxic (20% O2) conditions.
  • Expression of NKG2D ligands (MICA, MICB, ULBPs) and HIF-1α was analyzed.
  • Knockdown of HIF-1α and treatment with a nitric oxide donor were performed.

Main Results:

  • Hypoxia decreased cell surface MICA expression without increasing soluble MICA levels.
  • Osteosarcoma cells showed reduced susceptibility to NK cell cytotoxicity under hypoxia.
  • Hypoxia-induced HIF-1α expression mediated the downregulation of MICA.
  • Nitric oxide did not appear to influence MICA expression or HIF-1α levels.

Conclusions:

  • Hypoxia downregulates cell surface MICA expression in osteosarcoma cells via a HIF-1α-dependent pathway.
  • This downregulation contributes to reduced NK cell-mediated killing of tumor cells under hypoxic conditions.
  • The observed effects of hypoxia are independent of nitric oxide production.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...